QA: Globeimmune INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001245104_2016_Globeimmune_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001245104, Globeimmune INC

  xvar xval
0 AssetsCurrent 11,090,775
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 209,721
3 remainder_Assets 205,645
4 LiabilitiesCurrent 4,225,439
5 LiabilitiesNoncurrent 171,500
6 remainder_Liabilities 4,120,802
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,554,165
9 ResearchAndDevelopmentExpense 4,483,138
10 remainder_Expenses 187,335
11 remainder_Revenues 6,457,733
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,506,141
1 Liabilities 8,517,741
2 Expenses 9,224,638
3 Revenues 6,457,733
4 StockholdersEquity 2,988,400
5 NetIncome -2,766,905
6 ComprehensiveNetIncome -2,766,905
7 BaseVar 17,853,126
8 EconomicCapitalRatiobeforeLimitedLiability 0.374
9 EconomicCapitalRatio 1.77

Edgar->Model Mapping

Feature Distribution

Change over Time